Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria.

Yeo TW, Bush PA, Chen Y, Young SP, Zhang H, Millington DS, Granger DL, Mwaikambo ED, Anstey NM, Weinberg JB.

FASEB J. 2019 Oct 26:fj201901048RR. doi: 10.1096/fj.201901048RR. [Epub ahead of print]

PMID:
31658834
2.

Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.

Yeo TW, Weinberg JB, Lampah DA, Kenangalem E, Bush P, Chen Y, Price RN, Young S, Zhang HY, Millington D, Granger DL, Anstey NM.

Clin Infect Dis. 2019 Oct 30;69(10):1712-1720. doi: 10.1093/cid/ciz038.

3.

Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria.

Rubach MP, Zhang H, Florence SM, Mukemba JP, Kalingonji AR, Anstey NM, Yeo TW, Lopansri BK, Thompson JW, Mwaikambo ED, Young S, Millington DS, Weinberg JB, Granger DL.

Infect Immun. 2019 Mar 25;87(4). pii: e00655-18. doi: 10.1128/IAI.00655-18. Print 2019 Apr.

4.

Combination of nutrients in a mammalian cell culture medium kills cryptococci.

Granger DL, Call DM.

Med Mycol. 2019 Apr 1;57(3):374-383. doi: 10.1093/mmy/myy040.

PMID:
29878229
5.

Decreased Microvascular Function in Tanzanian Children With Severe and Uncomplicated Falciparum Malaria.

Yeo TW, Florence SM, Kalingonji AR, Chen Y, Granger DL, Anstey NM, Mwaikambo ED, Weinberg JB.

Open Forum Infect Dis. 2017 Apr 22;4(2):ofx079. doi: 10.1093/ofid/ofx079. eCollection 2017 Spring.

6.

Monocyte polarization in children with falciparum malaria: relationship to nitric oxide insufficiency and disease severity.

Weinberg JB, Volkheimer AD, Rubach MP, Florence SM, Mukemba JP, Kalingonji AR, Langelier C, Chen Y, Bush M, Yeo TW, Granger DL, Anstey NM, Mwaikambo ED.

Sci Rep. 2016 Jul 7;6:29151. doi: 10.1038/srep29151.

7.

Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Weinberg JB, Hyland K, Granger DL, Anstey NM.

PLoS Pathog. 2015 Mar 12;11(3):e1004667. doi: 10.1371/journal.ppat.1004667. eCollection 2015 Mar.

8.

Impaired systemic tetrahydrobiopterin bioavailability and increased oxidized biopterins in pediatric falciparum malaria: association with disease severity.

Rubach MP, Mukemba J, Florence S, Lopansri BK, Hyland K, Volkheimer AD, Yeo TW, Anstey NM, Weinberg JB, Mwaikambo ED, Granger DL.

PLoS Pathog. 2015 Mar 12;11(3):e1004655. doi: 10.1371/journal.ppat.1004655. eCollection 2015 Mar.

9.

Quantification of Plasmodium falciparum histidine-rich protein-2 in cerebrospinal spinal fluid from cerebral malaria patients.

Mikita K, Thakur K, Anstey NM, Piera KA, Pardo CA, Weinberg JB, Mukemba J, Florence S, Mwaikambo ED, Granger DL, Sullivan DJ.

Am J Trop Med Hyg. 2014 Sep;91(3):486-92. doi: 10.4269/ajtmh.14-0210. Epub 2014 Jun 30.

10.

Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Weinberg JB, Granger DL, Price RN, Anstey NM.

J Infect Dis. 2014 Nov 15;210(10):1627-32. doi: 10.1093/infdis/jiu308. Epub 2014 May 30.

11.

Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.

Weinberg JB, Yeo TW, Mukemba JP, Florence SM, Volkheimer AD, Wang H, Chen Y, Rubach M, Granger DL, Mwaikambo ED, Anstey NM.

J Infect Dis. 2014 Sep 15;210(6):913-22. doi: 10.1093/infdis/jiu156. Epub 2014 Mar 11.

12.

Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children.

Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, Yeo TW, Piera KA, Alder SC, Weinberg JB, Anstey NM, Granger DL, Mwaikambo ED.

PLoS One. 2012;7(5):e35985. doi: 10.1371/journal.pone.0035985. Epub 2012 May 7.

13.

A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

Malar J. 2010 Oct 29;9:302. doi: 10.1186/1475-2875-9-302.

14.

Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

J Infect Dis. 2010 Jul 1;202(1):117-24. doi: 10.1086/653125.

15.

Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome.

Yeo TW, Lampah DA, Tjitra E, Gitawati R, Darcy CJ, Jones C, Kenangalem E, McNeil YR, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM.

PLoS Pathog. 2010 Apr 22;6(4):e1000868. doi: 10.1371/journal.ppat.1000868. Erratum in: PLoS Pathog. 2010;6(5). doi: 10.1371/annotation/e49842d3-ea72-45a4-93d4-2f494baee962.

16.

Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB.

Hum Genet. 2010 Feb;127(2):163-82. doi: 10.1007/s00439-009-0753-3. Epub 2009 Oct 27.

17.

Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria.

Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM.

J Infect Dis. 2009 Nov 15;200(10):1522-9. doi: 10.1086/644641.

18.

Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria.

Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL.

Curr Opin Infect Dis. 2008 Oct;21(5):468-75. doi: 10.1097/QCO.0b013e32830ef5cf. Review.

19.

Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations.

Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM.

J Infect Dis. 2008 Aug 15;198(4):602-8. doi: 10.1086/590209.

20.

Safety profile of L-arginine infusion in moderately severe falciparum malaria.

Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Granger DL, Weinberg JB, Lopansri BK, Price RN, Celermajer DS, Duffull SB, Anstey NM.

PLoS One. 2008 Jun 11;3(6):e2347. doi: 10.1371/journal.pone.0002347.

21.

Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.

Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM.

J Exp Med. 2007 Oct 29;204(11):2693-704. Epub 2007 Oct 22.

22.

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, Tjitra E, Maniboey H, Hobbs MR, Levesque MC, Weinberg JB, Granger DL.

Infect Immun. 2006 Jun;74(6):3355-9.

23.

Impaired systemic production of prostaglandin E2 in children with cerebral malaria.

Perkins DJ, Hittner JB, Mwaikambo ED, Granger DL, Weinberg JB, Anstey NM.

J Infect Dis. 2005 May 1;191(9):1548-57. Epub 2005 Mar 31.

PMID:
15809915
25.

Salmonella enterica serovar Typhimurium RamA, intracellular oxidative stress response, and bacterial virulence.

van der Straaten T, Zulianello L, van Diepen A, Granger DL, Janssen R, van Dissel JT.

Infect Immun. 2004 Feb;72(2):996-1003.

26.

Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.

Boutlis CS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Anstey NM.

Am J Trop Med Hyg. 2003 Dec;69(6):569-73.

PMID:
14740870
27.

Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice.

McClelland EE, Granger DL, Potts WK.

Infect Immun. 2003 Aug;71(8):4815-7.

28.

Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production.

Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL.

Lancet. 2003 Feb 22;361(9358):676-8.

PMID:
12606182
29.

A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.

Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB.

Lancet. 2002 Nov 9;360(9344):1468-75. Erratum in: Lancet. 2003 Feb 1;361(9355):438..

PMID:
12433515
30.

A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production.

Morahan G, Boutlis CS, Huang D, Pain A, Saunders JR, Hobbs MR, Granger DL, Weinberg JB, Peshu N, Mwaikambo ED, Marsh K, Roberts DJ, Anstey NM.

Genes Immun. 2002 Nov;3(7):414-8.

31.

Novel Salmonella enterica serovar Typhimurium protein that is indispensable for virulence and intracellular replication.

van der Straaten T, van Diepen A, Kwappenberg K, van Voorden S, Franken K, Janssen R, Kusters JG, Granger DL, van Dissel JT.

Infect Immun. 2001 Dec;69(12):7413-8.

32.

Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.

Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB.

J Infect Dis. 1999 Dec;180(6):1994-2002. Erratum in: J Infect Dis 2000 Jan;181(1):408.

PMID:
10558957
33.

Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children.

Anstey NM, Weinberg JB, Wang Z, Mwaikambo ED, Duffy PE, Granger DL.

Am J Trop Med Hyg. 1999 Aug;61(2):253-8.

PMID:
10463676
34.

Nitric oxide, malaria, and anemia: inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children.

Anstey NM, Granger DL, Hassanali MY, Mwaikambo ED, Duffy PE, Weinberg JB.

Am J Trop Med Hyg. 1999 Aug;61(2):249-52.

PMID:
10463675
35.

Noncardiogenic pulmonary edema during vivax malaria.

Curlin ME, Barat LM, Walsh DK, Granger DL.

Clin Infect Dis. 1999 May;28(5):1166-7. No abstract available.

PMID:
10452658
36.

Comparison of oral and tympanic temperatures in a Veterans Administration outpatient clinic.

Abolnik IZ, Kithas PA, McDonnald JJ, Soller JB, Izrailevsky YA, Granger DL.

Am J Med Sci. 1999 May;317(5):301-3.

PMID:
10334117
37.

Measuring nitric oxide production in human clinical studies.

Granger DL, Anstey NM, Miller WC, Weinberg JB.

Methods Enzymol. 1999;301:49-61. Review. No abstract available.

PMID:
9919553
38.

Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.

Chang YC, Cherniak R, Kozel TR, Granger DL, Morris LC, Weinhold LC, Kwon-Chung KJ.

Infect Immun. 1997 May;65(5):1584-92.

39.

Nitrate levels in malaria.

Anstey NM, Granger DL, Weinberg JB.

Trans R Soc Trop Med Hyg. 1997 Mar-Apr;91(2):238-40. No abstract available.

PMID:
9196781
40.

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.

Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL.

J Exp Med. 1996 Aug 1;184(2):557-67.

41.

High-output nitric oxide: weapon against infection?

Granger DL, Hibbs JB Jr.

Trends Microbiol. 1996 Feb;4(2):46-7. No abstract available.

PMID:
8820563
42.

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction.

Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr.

Methods Enzymol. 1996;268:142-51. No abstract available.

PMID:
8782580
43.

Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity.

Caniza MA, Granger DL, Wilson KH, Washington MK, Kordick DL, Frush DP, Blitchington RB.

Clin Infect Dis. 1995 Jun;20(6):1505-11.

PMID:
7548500
44.
46.

Infectious arthritis due to Propionibacterium acnes in a prosthetic joint.

Sulkowski MS, Abolnik IZ, Morris EI, Granger DL.

Clin Infect Dis. 1994 Jul;19(1):224-5. No abstract available.

PMID:
7948550
47.

N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection.

Bastian NR, Xu S, Shao XL, Shelby J, Granger DL, Hibbs JB Jr.

Biochim Biophys Acta. 1994 May 25;1226(2):225-31.

PMID:
7515690
48.

Nitric oxide produced during murine listeriosis is protective.

Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs JB Jr, Kurlander RL.

Infect Immun. 1994 Mar;62(3):1089-100.

50.

Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.

Evans TG, Thai L, Granger DL, Hibbs JB Jr.

J Immunol. 1993 Jul 15;151(2):907-15.

PMID:
8335918

Supplemental Content

Loading ...
Support Center